{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:16:45Z","timestamp":1773735405472,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.7759\/cureus.105352","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:05:22Z","timestamp":1773727522000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperparathyroidism-Jaw Tumor Syndrome: A Rare Case"],"prefix":"10.7759","author":[{"given":"Kunal","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adlyne Reena","family":"Asirvatham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shriraam","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorai","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayanan","family":"Cunnigaiper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten JD","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, et al.. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002, 32:676-80. 10.1038\/ng1048","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S115993","article-title":"Hyperparathyroidism-jaw tumor syndrome: current perspectives","volume":"9","author":"Mehta A","year":"2016","unstructured":"Mehta A, Patel D, Rosenberg A, et al.. Hyperparathyroidism-jaw tumor syndrome: current perspectives. Onco Targets Ther. 2016, 9:7345-51. 10.2147\/OTT.S115993","journal-title":"Onco Targets Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.6.8964825","article-title":"Evaluation and management of primary hyperparathyroidism","volume":"81","author":"Silverberg SJ","year":"1996","unstructured":"Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996, 81:2036-40. 10.1210\/jcem.81.6.8964825","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker MD","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018, 14:115-25. 10.1038\/nrendo.2017.104","journal-title":"Nat Rev Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01422.x","article-title":"Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features","volume":"257","author":"Bilezikian JP","year":"2005","unstructured":"Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005, 257:6-17. 10.1111\/j.1365-2796.2004.01422.x","journal-title":"J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1993.tb01017.x","article-title":"The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years","volume":"234","author":"Larsson K","year":"1993","unstructured":"Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E, Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med. 1993, 234:585-93. 10.1111\/j.1365-2796.1993.tb01017.x","journal-title":"J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla S","year":"1999","unstructured":"Khosla S, Melton LJ III, Wermers RA, Crowson CS, O'Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res. 1999, 14:1700-7. 10.1359\/jbmr.1999.14.10.1700","journal-title":"J Bone Miner Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12262-011-0306-6","article-title":"Case report on giant parathyroid adenoma with review of literature","volume":"75","author":"Sisodiya R","year":"2013","unstructured":"Sisodiya R, Kumar S, Palankar N, BV D. Case report on giant parathyroid adenoma with review of literature. Indian J Surg. 2013, 75:21-2. 10.1007\/s12262-011-0306-6","journal-title":"Indian J Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15386\/cjmed-638","article-title":"Primary hyperparathyroidism-jaw tumor syndrome: a confusing and forgotten diagnosis","volume":"89","author":"Piciu D","year":"2016","unstructured":"Piciu D, Piciu A, Barbus E, Pestean C, Larg MI, Fetica B. Primary hyperparathyroidism-jaw tumor syndrome: a confusing and forgotten diagnosis. Clujul Med. 2016, 89:555-8. 10.15386\/cjmed-638","journal-title":"Clujul Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0066","article-title":"Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism","volume":"15","author":"Masi G","year":"2008","unstructured":"Masi G, Barzon L, Iacobone M, et al.. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer. 2008, 15:1115-26. 10.1677\/ERC-08-0066","journal-title":"Endocr Relat Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-016-0519-0","article-title":"Hyperparathyroidism jaw tumour syndrome: a pictorial review","volume":"7","author":"Du Preez H","year":"2016","unstructured":"Du Preez H, Adams A, Richards P, Whitley S. Hyperparathyroidism jaw tumour syndrome: a pictorial review. Insights Imaging. 2016, 7:793-800. 10.1007\/s13244-016-0519-0","journal-title":"Insights Imaging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin K","year":"2017","unstructured":"van der Tuin K, Tops CM, Adank MA, et al.. CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism. J Clin Endocrinol Metab. 2017, 102:4534-40. 10.1210\/jc.2017-01249","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.041723","article-title":"Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour","volume":"43","author":"Scott RH","year":"2006","unstructured":"Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006, 43:705-15. 10.1136\/jmg.2006.041723","journal-title":"J Med Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2007.11.010","article-title":"Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy","volume":"206","author":"Phitayakorn R","year":"2008","unstructured":"Phitayakorn R, McHenry CR. Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J Am Coll Surg. 2008, 206:1106-15. 10.1016\/j.jamcollsurg.2007.11.010","journal-title":"J Am Coll Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01874.x","article-title":"The role of calcimimetics in the treatment of hyperparathyroidism","volume":"37","author":"W\u00fcthrich RP","year":"2007","unstructured":"W\u00fcthrich RP, Martin D, Bilezikian JP. The role of calcimimetics in the treatment of hyperparathyroidism. Eur J Clin Invest. 2007, 37:915-22. 10.1111\/j.1365-2362.2007.01874.x","journal-title":"Eur J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/415719","article-title":"Cinacalcet treatment of primary hyperparathyroidism","volume":"2011","author":"Rothe HM","year":"2011","unstructured":"Rothe HM, Liangos O, Biggar P, Petermann A, Ketteler M. Cinacalcet treatment of primary hyperparathyroidism. Int J Endocrinol. 2011, 2011:415719. 10.1155\/2011\/415719","journal-title":"Int J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism","volume":"63","author":"Moosgaard B","year":"2005","unstructured":"Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol. 2005, 63:506-13. 10.1111\/j.1365-2265.2005.02371.x","journal-title":"Clin Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/js.2016-1089","article-title":"Hyperparathyroidism-jaw tumor syndrome associated with large-scale 1q31 deletion","volume":"1","author":"Rubinstein JC","year":"2017","unstructured":"Rubinstein JC, Majumdar SK, Laskin W, Lazaga F, Prasad ML, Carling T, Khan SA. Hyperparathyroidism-jaw tumor syndrome associated with large-scale 1q31 deletion. J Endocr Soc. 2017, 1:926-30. 10.1210\/js.2016-1089","journal-title":"J Endocr Soc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04184.x","article-title":"Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism","volume":"76","author":"Domingues R","year":"2012","unstructured":"Domingues R, Tomaz RA, Martins C, Nunes C, Bugalho MJ, Cavaco BM. Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2012, 76:33-8. 10.1111\/j.1365-2265.2011.04184.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25067","article-title":"Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion","volume":"9","author":"Muscarella LA","year":"2018","unstructured":"Muscarella LA, Turchetti D, Fontana A, et al.. Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion. Oncotarget. 2018, 9:20721-33. 10.18632\/oncotarget.25067","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426564-hyperparathyroidism-jaw-tumor-syndrome-a-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:05:23Z","timestamp":1773727523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426564-hyperparathyroidism-jaw-tumor-syndrome-a-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.105352","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}